期刊文献+

阿片类药物在肝肾功能不全癌痛患者中的选择应用 被引量:34

Selective Opioid Usage for Cancer Pain in Patients with Hepatic or Renal Dysfunction
原文传递
导出
摘要 阿片类药物是控制癌痛的必备药物。对于癌症合并有肝肾功能不全的患者,阿片类药物的选择应慎重。吗啡的缓释剂型应注意调整剂量和给药的间隔时间,即释剂型可临时应用。应禁用可待因。轻中度的肝肾功能不全患者,羟考酮的应用是安全的;但重度肾功能不全者禁用羟考酮。芬太尼透皮贴剂是重度肝肾功能不全患者和透析患者的首选。丁丙诺啡在某些情况下可代替芬太尼应用于透析患者。 Opioid is essential drug for cancer pain.It should be very careful to choose opioid drugs for patients with hepatic or renal dysfunction.Dose and dosing interval of the sustained-released formulation of morphine should be adjusted,while the immediate-released formulation could be prescribed temporarily.Codeine should be forbidden.Oxycodone is safe for patients with mild or moderate hepatic or renal dysfunction,but should not be used in ones with severe renal dysfunction.Transdermal fentanyl is the first choice for patients with severe hepatic or renal dysfunction,and for dialytic patients.However,in some cases buprenorphine could replace it for dialytic patients.
作者 程熠 于世英
出处 《中国肿瘤》 CAS 2011年第4期278-282,共5页 China Cancer
关键词 阿片类药物 肝肾功能不全 癌痛 opioid drugs hepatic or renal dysfunction cancer pain
  • 相关文献

参考文献16

二级参考文献54

  • 1邓铸强.开胸手术后选择静脉与硬膜外病人自控镇痛的比较[J].海南医学,2005,16(5):25-26. 被引量:5
  • 2胡红丰,汪红华,方明艳.布洛羟考酮片[J].中国新药杂志,2005,14(11):1362-1363. 被引量:1
  • 3刘艳丽,亓佳,吴春福,宫泽辉.羟考酮精神依赖的形成与纹状体多巴胺释放的关系[J].中国药理学与毒理学杂志,2006,20(1):44-47. 被引量:8
  • 4Gupta SK, Southam M, Gale R, et al. System functionality and physicochemical model of fentanyl transdermal system. J Pain Symptom Manage, 1992, 7:17~26.
  • 5Lehmann KA, Zech D. Transdermal fentanyl: clinical pharmacology. J Pain Symptom Manage,1992,7:8~16.
  • 6Roy SD, Hou SY, Witham SL, et al. Transdermal delivery of narcotic analgesics: comparative metabolism and permeability of human cadaver skin and hairless mouse skin. J Pharm Sci,1994,83:1723~1728.
  • 7Gourlay GK, Kowalski SR, Plummer JL, et al. The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects. Pain,1989,37:193~202.
  • 8Gourlay GK, Kowalski SR, Plummer JL, et al. The efficacy of transdermal fentanyl in the treatment of postoperative pain: a double-blind comparison of fentanyl and placebo systems. Pain,1990,40:21~28.
  • 9Varvel JR, Shafer SL, Hwang SS, et al. Absorption characteristics of transdermally administered fentanyl. Anesthesiology,1989,70:928~936.
  • 10Grond S, Radbruch L, Lehmann KA. Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl. Clin Pharcokinet,2000,38:59~89.

共引文献160

同被引文献251

引证文献34

二级引证文献194

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部